Lisa Ricciardi, President and CEO of Cognition Therapeutics, was recently a guest on Benzinga's All-Access. Cognition ...

What’s exciting is that medications that block CXCR3 are already being tested for other health problems, like arthritis. If ...

Dementia affects more than 6 million Americans and accounts for more than 100,000 deaths each year, with a startling NYU ...

Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

Dr. Joel Salinas, a behavioral neurologist and associate professor at NYU Grossman School of Medicine, discusses what’s ...

Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are ...

A study of almost 34,000 people in rural China has revealed that lowering blood pressure can reduce the risk of dementia in ...

New research provides further evidence that getting uncontrolled high blood pressure under control could be one way to reduce ...

Reducing high blood pressure substantially lowers the risk of dementia and cognitive impairment without dementia, according ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...

Lowering high blood pressure reduces dementia risk by 15%, as shown in a clinical trial involving 34,000 patients in China.

Digitally engaging with technology correlated to a 58% lower risk of cognitive impairment, contrary to fears of “digital ...